BioWorld Science

April 30, 2012

View Archived Issues

Amgen offers pipeline update for first quarter 2012

Read More

GSK reflects on achievements of first quarter 2012

Read More

U.K. study reveals new potential marker of acute kidney injury in acute on chronic liver failure

Read More

Promising candidate biomarker of venous thrombosis uncovered

Read More

Responses to sodium oxybate vary in phase I/II trial

Read More

FDA approves sNDA for Votrient

Read More

Afinitor approved in U.S. for new indication

Read More

Novel PLK1 inhibitor exhibits antitumor activity in vivo

Read More

Double-blind trial assesses extended-release once-daily epilepsy drug

Read More

Shionogi submits NDA for tablets to treat vulvar and vaginal atrophy

Read More

BioAlliance Pharma provides update on AMEP biotherapy

Read More

Repligen reports on RG-1068 NDA

Read More

Sanofi vaccine approved in Japan to prevent acute flaccid poliomyelitis

Read More

Orphan drug reverses vision loss in patients with Leber's hereditary optic neuropathy

Read More

Novel telomerase inhibitors developed at Pharminox

Read More

Almirall presents new SYK/JAK inhibitors

Read More

Proximagen designs novel chemokine CCR2 receptor antagonists

Read More

New monoamine reuptake inhibitors discovered in China

Read More

Kissei Pharmaceutical patents new indolizine derivatives

Read More

FDA approves new product to treat erectile dysfunction

Read More

Manhattan Pharmaceuticals to change name

Read More

Pivotal macitentan study meets primary endpoint

Read More

Athersys discusses development of cell therapy with FDA

Read More

Trimel gives update on special population study of male hypogonadism treatment

Read More

Algeta and Sanofi extend research collaboration

Read More